In this study, we aimed to demonstrate the effects of TRE on the pathogenic changes associated with MASH, including glucose and insulin sensitivity and hyperinsulinemia, and, more importantly, on liver tumor growth in two models of MASH-driven HCC. The gene discussed is INS; the disease is hyperinsulinism.